Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1990 Jan;99(1):31–34. doi: 10.1111/j.1476-5381.1990.tb14649.x

Responses to noradrenaline in human subcutaneous resistance arteries are mediated by both alpha 1- and alpha 2-adrenoceptors.

H Nielsen 1, F V Mortensen 1, M J Mulvany 1
PMCID: PMC1917507  PMID: 1970494

Abstract

1. In vitro experiments in a microvascular myograph were designed to characterize postjunctional alpha-adrenoceptors of human subcutaneous resistance arteries (normalised internal diameter 143-313 microns). 2. Both the alpha 1-selective agonist phenylephrine in the presence of 0.3 microM yohimbine and the alpha 2-selective agonist B-HT 933 in the presence of 0.3 microM prazosin elicited prominent and concentration-dependent contractions. The maximum response to phenylephrine and B-HT 933 was not different from the response to high K physiological salt solution (125 mM K+), and the pD2 values (-log EC50) were 5.90 and 6.11, respectively. 3. In the presence of the alpha 2-selective antagonist yohimbine (0.3 microM), the alpha 1-selective antagonist prazosin competitively antagonised the responses to phenylephrine; the pA2 of prazosin for the receptor which mediated the response to phenylephrine was 8.41. 4. Blockade of either alpha 2-adrenoceptors with 0.1 microM yohimbine or alpha 1-adrenoceptors with 0.1 microM prazosin caused shifts to the right of the noradrenaline concentration-response curves and the shifts in pD2 were 0.69 and 0.61, respectively. The combination of the two antagonists at the above-mentioned concentrations caused a marked, parallel shift to the right of the noradrenaline concentration-response curve, the shift of the pD2 was 2.68. 5. These results suggest that activation of both alpha 1- and alpha 2-adrenoceptors produces contractions in human subcutaneous resistance arteries, and that responses to noradrenaline in these vessels are mediated by both alpha-adrenoceptor subtypes.

Full text

PDF
31

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Alabaster V., Davey M. Precapillary vessels: effects of the sympathetic nervous system and of catecholamines. J Cardiovasc Pharmacol. 1984;6 (Suppl 2):S365–S376. [PubMed] [Google Scholar]
  3. Busija D. W., Leffler C. W. Postjunctional alpha 2-adrenoceptors in pial arteries of anesthetized newborn pigs. Dev Pharmacol Ther. 1987;10(1):36–46. doi: 10.1159/000457726. [DOI] [PubMed] [Google Scholar]
  4. De Mey J., Vanhoutte P. M. Uneven distribution of postjunctional alpha 1-and alpha 2-like adrenoceptors in canine arterial and venous smooth muscle. Circ Res. 1981 Jun;48(6 Pt 1):875–884. doi: 10.1161/01.res.48.6.875. [DOI] [PubMed] [Google Scholar]
  5. Drew G. M. Pharmacological characterisation of the presynaptic alpha-adrenoceptor in the rat vas deferens. Eur J Pharmacol. 1977 Mar 21;42(2):123–130. doi: 10.1016/0014-2999(77)90351-x. [DOI] [PubMed] [Google Scholar]
  6. Drew G. M. What do antagonists tell us about alpha-adrenoceptors? Clin Sci (Lond) 1985;68 (Suppl 10):15s–19s. doi: 10.1042/cs068s015. [DOI] [PubMed] [Google Scholar]
  7. Ekenvall L., Lindblad L. E., Norbeck O., Etzell B. M. alpha-Adrenoceptors and cold-induced vasoconstriction in human finger skin. Am J Physiol. 1988 Nov;255(5 Pt 2):H1000–H1003. doi: 10.1152/ajpheart.1988.255.5.H1000. [DOI] [PubMed] [Google Scholar]
  8. Elliott H. L., Reid J. L. Evidence for postjunctional vascular alpha 2-adrenoceptors in peripheral vascular regulation in man. Clin Sci (Lond) 1983 Sep;65(3):237–241. doi: 10.1042/cs0650237. [DOI] [PubMed] [Google Scholar]
  9. Faber J. E. In situ analysis of alpha-adrenoceptors on arteriolar and venular smooth muscle in rat skeletal muscle microcirculation. Circ Res. 1988 Jan;62(1):37–50. doi: 10.1161/01.res.62.1.37. [DOI] [PubMed] [Google Scholar]
  10. Flavahan N. A., Cooke J. P., Shepherd J. T., Vanhoutte P. M. Human postjunctional alpha-1 and alpha-2 adrenoceptors: differential distribution in arteries of the limbs. J Pharmacol Exp Ther. 1987 May;241(2):361–365. [PubMed] [Google Scholar]
  11. Goldberg M. R., Robertson D. Evidence for the existence of vascular alpha 2-adrenergic receptors in humans. Hypertension. 1984 Jul-Aug;6(4):551–556. doi: 10.1161/01.hyp.6.4.551. [DOI] [PubMed] [Google Scholar]
  12. Jones S. B., Smith J. M., Jones A. W., Bylund D. B. Alpha-1 adrenergic receptor binding in aortas from rat and dog: comparison of [3H]prazosin and beta-iodo-[125I]-4-hydroxyphenyl-ethyl-aminomethyl-tetralone. J Pharmacol Exp Ther. 1987 Jun;241(3):875–881. [PubMed] [Google Scholar]
  13. Langer S. Z., Hicks P. E. Alpha-adrenoreceptor subtypes in blood vessels: physiology and pharmacology. J Cardiovasc Pharmacol. 1984;6 (Suppl 4):S547–S558. doi: 10.1097/00005344-198406004-00001. [DOI] [PubMed] [Google Scholar]
  14. Moulds R. J., Jauernig R. A. Mechanism of prazosin collapse. Lancet. 1977 Jan 22;1(8004):200–201. doi: 10.1016/s0140-6736(77)91808-6. [DOI] [PubMed] [Google Scholar]
  15. Mulvany M. J., Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res. 1977 Jul;41(1):19–26. doi: 10.1161/01.res.41.1.19. [DOI] [PubMed] [Google Scholar]
  16. Nielsen H., Thom S. M., Hughes A. D., Martin G. N., Mulvany M. J., Sever P. S. Postjunctional alpha 2-adrenoceptors mediate vasoconstriction in human subcutaneous resistance vessels. Br J Pharmacol. 1989 Jul;97(3):829–834. doi: 10.1111/j.1476-5381.1989.tb12022.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ruffolo R. R., Jr Interactions of agonists with peripheral alpha-adrenergic receptors. Fed Proc. 1984 Nov;43(14):2910–2916. [PubMed] [Google Scholar]
  18. Schümann H. J., Lues I. Postjunctional alpha-adrenoceptors in the isolated saphenous vein of the rabbit. Characterization and influence of angiotensin. Naunyn Schmiedebergs Arch Pharmacol. 1983 Aug;323(4):328–334. doi: 10.1007/BF00512471. [DOI] [PubMed] [Google Scholar]
  19. Sjöberg T., Steen S., Skärby T., Norgren L., Andersson K. E. Postjunctional alpha-adrenoceptors in human superficial epigastric arteries and veins. Pharmacol Toxicol. 1987 Jan;60(1):43–50. doi: 10.1111/j.1600-0773.1987.tb01717.x. [DOI] [PubMed] [Google Scholar]
  20. Skärby T. V., Andersson K. E., Edvinsson L. Pharmacological characterization of postjunctional alpha-adrenoceptors in isolated feline cerebral and peripheral arteries. Acta Physiol Scand. 1983 Jan;117(1):63–73. doi: 10.1111/j.1748-1716.1983.tb07179.x. [DOI] [PubMed] [Google Scholar]
  21. Starke K., Endo T., Taube H. D. Relative pre- and postsynaptic potencies of alpha-adrenoceptor agonists in the rabbit pulmonary artery. Naunyn Schmiedebergs Arch Pharmacol. 1975;291(1):55–78. doi: 10.1007/BF00510821. [DOI] [PubMed] [Google Scholar]
  22. Steen S., Sjöberg T., Skärby T. V., Norgren L., Andersson K. E. Postjunctional alpha 1- and alpha 2-adrenoceptors mediating contraction in isolated human groin arteries and veins. Acta Physiol Scand. 1984 Nov;122(3):323–329. doi: 10.1111/j.1748-1716.1984.tb07516.x. [DOI] [PubMed] [Google Scholar]
  23. Steen S., Skärby T. V., Norgren L., Andersson K. E. Pharmacological characterization of postjunctional alpha-adrenoceptors in isolated human omental arteries and veins. Acta Physiol Scand. 1984 Jan;120(1):109–116. doi: 10.1111/j.1748-1716.1984.tb07379.x. [DOI] [PubMed] [Google Scholar]
  24. Timmermans P. B., Kwa H. Y., van Zwieten P. A. Possible subdivision of postsynaptic alpha-adrenoceptors mediating pressor responses in the pithed rat. Naunyn Schmiedebergs Arch Pharmacol. 1979 Dec;310(2):189–193. doi: 10.1007/BF00500284. [DOI] [PubMed] [Google Scholar]
  25. Timmermans P. B., Van Zwieten P. A. Postsynaptic alpha 1- and alpha 2-adrenoceptors in the circulatory system of the pithed rat: selective stimulation of the alpha 2-type by B-HT 933. Eur J Pharmacol. 1980 May 2;63(2-3):199–202. doi: 10.1016/0014-2999(80)90446-x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES